DAWN / Day One Biopharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Day One Biopharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US23954D1090

Utestående aktier 102,431,933 shares
Insideraktier41 583 586 shares
Insynsägande40,60 %
Totalt antal insynspersoner23
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

-4 ( )

10918 out of 11304

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

-0.036 %( )

10276 out of 11220

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Day One Biopharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
AI Day 1 LLC 10% Owner - [10%] 12 929 322 12 929 322
Atlas Venture Associates XI, LLC 10% Owner - [10%] 250 000 766 667
Atlas Venture Fund XI, L.P. 10% Owner - [10%] 6 008 534 6 008 534
Atlas Venture Opportunity Fund I, L.P. 10% Owner - [10%] 793 116 793 116
Atlas Venture Opportunity Fund II, L.P. 10% Owner - [10%] 766 667 766 667
Becker Daniel J. Director - [D] 5 000 5 000
Jeremy Bender CHIEF EXECUTIVE OFFICER, Director - [D] [O] 1 770 203 1 770 203
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Blackman Samuel C. HEAD OF R&D - [O] 2 034 015 2 034 015
Len Blavatnik - 9 484 638 12 929 322
Canaan Partners XI LLC 10% Owner - [10%] 9 663 645 6 964 301
Canaan XI L.P. 10% Owner - [10%] 6 964 301 6 964 301
Adam Dubow Gen Counsel & Secretary - [O] 54 858 54 858
Garland J. Scott Director - [D] 0 0
Michael Gladstone Director - [D] 766 667 766 667
Holles Natalie C. Director - [D] 57 310 57 310
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Josey John A. Director - [D] 72 292 72 292
Lauren Merendino Chief Commercial Officer - [O] 41 931 41 931
Garry A Nicholson Director - [D] 0 0
Julie Papanek Director - [D] 2 880 761 2 880 761
Saira Ramasastry Director - [D] 40 485 40 485
Pharmaceutical Co Ltd Takeda 10% Owner - [10%] 6 120 124 6 120 124
Takeda Ventures, Inc. 10% Owner - [10%] 6 120 124 6 120 124
Charles N II York COO and CFO - [O] 278 000 278 000

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i DAWN / Day One Biopharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2023-10-20 AI Day 1 LLC 111 387 9,9734 111 387 9,9734 1 110 907 194 17.6900 859 529 77,37
2023-10-19 AI Day 1 LLC 384 400 10,0608 384 400 10,0608 3 867 372
2023-10-18 AI Day 1 LLC 979 667 10,2076 979 667 10,2076 10 000 049
2023-06-09 AI Day 1 LLC 769 230 13,0000 769 230 13,0000 9 999 990
2022-06-17 AI Day 1 LLC 1 200 000 15,0000 1 200 000 15,0000 18 000 000
2022-06-17 Atlas Venture Opportunity Fund II, L.P. 766 667 15,0000 766 667 15,0000 11 500 005
2022-01-20 AI Day 1 LLC 4 615 14,7293 4 615 14,7293 67 976
2022-01-19 AI Day 1 LLC 58 818 14,6990 58 818 14,6990 864 566
2022-01-18 AI Day 1 LLC 43 429 14,2616 43 429 14,2616 619 367

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

DAWN / Day One Biopharmaceuticals, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i DAWN / Day One Biopharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2025-08-18 Merendino Lauren 3 766 6,7671 3 766 6,7671 25 485 0 6.8100 162 0,64
2025-08-18 Bender Jeremy 16 058 6,7671 16 058 6,7671 108 666
2025-08-18 Dubow Adam 4 365 6,7671 4 365 6,7671 29 538
2025-08-18 York Charles N II 4 106 6,7671 4 106 6,7671 27 786
2025-05-16 Merendino Lauren 3 927 6,2579 3 927 6,2579 24 575
2025-05-16 York Charles N II 4 282 6,2579 4 282 6,2579 26 796
2025-05-16 Dubow Adam 4 552 6,2579 4 552 6,2579 28 486
2025-05-16 Bender Jeremy 13 964 6,2579 13 964 6,2579 87 385
2025-02-18 York Charles N II 4 370 11,9630 4 370 11,9630 52 278

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

DAWN / Day One Biopharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2025-08-19 2025-08-18 4 York Charles N II DAWN Common Stock S - Sale D 6,7671 −4 106 −28 278 000
2025-08-19 2025-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 282 106
2025-08-19 2025-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 282 106
2025-08-19 2025-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 268 856
2025-08-19 2025-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 266 606
2025-08-19 2025-08-18 4 Dubow Adam DAWN Common Stock S - Sale D 6,7671 −4 365 −30 54 858
2025-08-19 2025-08-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 59 223
2025-08-19 2025-08-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 59 223
2025-08-19 2025-08-15 4 Dubow Adam DAWN Common Stock M - Exercise D 1 750 51 849
2025-08-19 2025-08-15 4 Dubow Adam DAWN Common Stock M - Exercise D 2 963 50 099
2025-08-19 2025-08-18 4 Bender Jeremy DAWN Common Stock S - Sale D 6,7671 −16 058 −109 161 365
2025-08-19 2025-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 177 423
2025-08-19 2025-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 177 423
2025-08-19 2025-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 154 049
2025-08-19 2025-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 149 299
2025-08-19 2025-08-18 4 Merendino Lauren DAWN Common Stock S - Sale D 6,7671 −3 766 −25 41 931
2025-08-19 2025-08-15 4 Merendino Lauren DAWN Common Stock M - Exercise D 3 687 45 697
2025-08-19 2025-08-15 4 Merendino Lauren DAWN Common Stock M - Exercise D 3 687 45 697
2025-08-19 2025-08-15 4 Merendino Lauren DAWN Common Stock M - Exercise D 3 162 38 323
2025-07-14 2025-07-10 4 Bender Jeremy By Bender Revocable Trust DAWN Common Stock G - Gift I 179 417 1 408 285
2025-07-14 2025-07-10 4 Bender Jeremy DAWN Common Stock G - Gift I −179 417 18 197
2025-07-14 2025-07-10 4 Bender Jeremy DAWN Common Stock G - Gift I −199 202 20 204
2025-07-14 2025-07-10 4 Bender Jeremy By Bender Revocable Trust DAWN Common Stock G - Gift I 74 328 1 029 666
2025-07-14 2025-07-10 4 Bender Jeremy DAWN Common Stock G - Gift I −74 328 147 702
2025-07-14 2025-07-10 4 Bender Jeremy By Bender Revocable Trust DAWN Common Stock G - Gift I 148 312 955 338
2025-07-14 2025-07-10 4 Bender Jeremy DAWN Common Stock G - Gift I −148 312 14 450
2025-07-14 2024-07-02 4 Bender Jeremy By Bender Revocable Trust DAWN Common Stock G - Gift I 199 202 1 228 868
2025-05-19 2025-05-16 4 Dubow Adam DAWN Common Stock S - Sale D 6,2579 −4 552 −28 47 136
2025-05-19 2025-05-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 51 688
2025-05-19 2025-05-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 51 688
2025-05-19 2025-05-15 4 Dubow Adam DAWN Common Stock M - Exercise D 1 750 44 314
2025-05-19 2025-05-15 4 Dubow Adam DAWN Common Stock M - Exercise D 2 962 42 564
2025-05-19 2025-05-16 4 York Charles N II DAWN Common Stock S - Sale D 6,2579 −4 282 −27 265 231
2025-05-19 2025-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 269 513
2025-05-19 2025-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 269 513
2025-05-19 2025-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 256 263
2025-05-19 2025-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 254 013
2025-05-19 2025-05-16 4 Merendino Lauren DAWN Common Stock S - Sale D 6,2579 −3 927 −25 35 161
2025-05-19 2025-05-15 4 Merendino Lauren DAWN Common Stock M - Exercise D 3 687 39 088
2025-05-19 2025-05-15 4 Merendino Lauren DAWN Common Stock M - Exercise D 3 687 39 088
2025-05-19 2025-05-15 4 Merendino Lauren DAWN Common Stock M - Exercise D 3 162 31 714
2025-05-19 2025-05-16 4 Bender Jeremy DAWN Common Stock S - Sale D 6,2579 −13 964 −87 145 737
2025-05-19 2025-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 159 701
2025-05-19 2025-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 159 701
2025-05-19 2025-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 136 327
2025-05-19 2025-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 131 577
2025-02-28 3 Merendino Lauren DAWN Common Stock D 28 552
2025-02-21 2025-02-18 4 York Charles N II DAWN Common Stock S - Sale D 11,9630 −4 370 −52 252 638
2025-02-21 2025-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 257 008
2025-02-21 2025-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 257 008
2025-02-21 2025-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 243 758
2025-02-21 2025-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 241 508
2025-02-21 2025-02-18 4 Dubow Adam DAWN Common Stock S - Sale D 11,9630 −4 646 −56 39 602
2025-02-21 2025-02-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 44 248
2025-02-21 2025-02-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 44 248
2025-02-21 2025-02-15 4 Dubow Adam DAWN Common Stock M - Exercise D 1 750 36 874
2025-02-21 2025-02-15 4 Dubow Adam DAWN Common Stock M - Exercise D 2 962 35 124
2025-02-21 2025-02-18 4 Bender Jeremy DAWN Common Stock S - Sale D 11,9630 −12 048 −144 128 015
2025-02-21 2025-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 140 063
2025-02-21 2025-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 140 063
2025-02-21 2025-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 116 689
2025-02-21 2025-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 111 939
2024-12-12 2024-12-10 4 Blackman Samuel C. DAWN Common Stock S - Sale D 13,3113 −30 000 −399 1 034 015
2024-11-19 2024-11-18 4 Bender Jeremy DAWN Common Stock S - Sale D 13,2102 −10 554 −139 108 377
2024-11-19 2024-11-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 118 931
2024-11-19 2024-11-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 107 244
2024-11-19 2024-11-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 102 494
2024-11-19 2024-11-18 4 Blackman Samuel C. DAWN Common Stock S - Sale D 13,2102 −2 206 −29 1 064 015
2024-11-19 2024-11-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 6 062 1 066 221
2024-11-19 2024-11-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 437 1 060 159
2024-11-19 2024-11-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 058 722
2024-11-19 2024-11-18 4 Dubow Adam DAWN Common Stock S - Sale D 13,2102 −3 165 −42 32 162
2024-11-19 2024-11-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 35 327
2024-11-19 2024-11-15 4 Dubow Adam DAWN Common Stock M - Exercise D 1 750 31 640
2024-11-19 2024-11-15 4 Dubow Adam DAWN Common Stock M - Exercise D 2 962 29 890
2024-11-19 2024-11-18 4 York Charles N II DAWN Common Stock S - Sale D 13,2102 −2 602 −34 240 133
2024-11-19 2024-11-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 242 735
2024-11-19 2024-11-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 236 110
2024-11-19 2024-11-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 233 860
2024-11-12 2024-11-11 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,0994 −10 000 −161 1 057 535
2024-11-12 2024-11-08 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,1725 −18 255 −295 1 067 535
2024-11-08 2024-11-07 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,0326 −11 245 −180 1 085 790
2024-11-04 2024-10-31 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,0200 −500 −8 1 097 035
2024-09-12 2024-09-10 4 Blackman Samuel C. DAWN Common Stock S - Sale D 14,2225 −30 000 −427 1 097 535
2024-08-19 2024-08-16 4 Dubow Adam DAWN Common Stock S - Sale D 13,9991 −3 202 −45 26 928
2024-08-19 2024-08-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 30 130
2024-08-19 2024-08-15 4 Dubow Adam DAWN Common Stock M - Exercise D 1 750 26 443
2024-08-19 2024-08-15 4 Dubow Adam DAWN Common Stock M - Exercise D 2 962 24 693
2024-08-19 2024-08-16 4 York Charles N II DAWN Common Stock S - Sale D 13,9991 −2 633 −37 232 485
2024-08-19 2024-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 235 118
2024-08-19 2024-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 228 493
2024-08-19 2024-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 226 243
2024-08-19 2024-08-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 13,9991 −2 232 −31 1 127 535
2024-08-19 2024-08-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 6 062 1 129 767
2024-08-19 2024-08-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 437 1 123 705
2024-08-19 2024-08-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 122 268
2024-08-19 2024-08-16 4 Bender Jeremy DAWN Common Stock S - Sale D 13,9991 −10 681 −150 98 932
2024-08-19 2024-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 109 613
2024-08-19 2024-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 97 926
2024-08-19 2024-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 93 176
2024-07-17 2024-07-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,0113 −20 000 −320 1 121 081
2024-07-05 2024-07-02 4 Bender Jeremy By Bender Revocable Trust DAWN Common Stock G - Gift I 72 612 807 026
2024-07-05 2024-07-02 4 Bender Jeremy DAWN Common Stock G - Gift I −72 612 197 614
2024-07-05 2024-07-02 4 Bender Jeremy By Bender Revocable Trust DAWN Common Stock G - Gift I 80 619 734 414
2024-07-05 2024-07-02 4 Bender Jeremy DAWN Common Stock G - Gift I −80 619 219 406
2024-07-05 2024-07-02 4 Bender Jeremy By Bender Revocable Trust DAWN Common Stock G - Gift I 29 606 653 795
2024-07-05 2024-07-02 4 Bender Jeremy DAWN Common Stock G - Gift I −29 606 222 030
2024-07-05 2024-07-02 4 Bender Jeremy By Bender Revocable Trust DAWN Common Stock G - Gift I 59 075 624 189
2024-07-05 2024-07-02 4 Bender Jeremy DAWN Common Stock G - Gift I −59 075 162 762
2024-06-21 2024-06-21 4 Ramasastry Saira DAWN Common Stock S - Sale D 13,1877 −10 000 −132 40 485
2024-06-12 2024-06-10 4 Blackman Samuel C. DAWN Common Stock S - Sale D 12,6196 −30 000 −379 1 141 081
2024-05-17 2024-05-16 4 Bender Jeremy DAWN Common Stock S - Sale D 16,0787 −7 873 −127 654 728
2024-05-17 2024-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 662 601
2024-05-17 2024-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 650 914
2024-05-17 2024-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 646 164
2024-05-17 2024-05-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,0787 −2 267 −36 1 171 081
2024-05-17 2024-05-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 6 062 1 173 348
2024-05-17 2024-05-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 437 1 167 286
2024-05-17 2024-05-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 165 849
2024-05-17 2024-05-16 4 York Charles N II DAWN Common Stock S - Sale D 16,0787 −2 675 −43 224 868
2024-05-17 2024-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 227 543
2024-05-17 2024-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 220 918
2024-05-17 2024-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 218 668
2024-05-17 2024-05-16 4 Dubow Adam DAWN Common Stock S - Sale D 16,0787 −3 253 −52 21 731
2024-05-17 2024-05-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 24 984
2024-05-17 2024-05-15 4 Dubow Adam DAWN Common Stock M - Exercise D 1 750 21 297
2024-05-17 2024-05-15 4 Dubow Adam DAWN Common Stock M - Exercise D 2 962 19 547
2024-05-14 2024-05-10 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,3743 −10 000 −164 1 164 662
2024-05-03 2024-05-03 4 Bender Jeremy DAWN Common Stock S - Sale D 17,8520 −9 154 −163 642 602
2024-05-03 2024-05-02 4 Bender Jeremy DAWN Common Stock S - Sale D 17,9375 −6 −0 651 756
2024-05-03 2024-05-01 4 Bender Jeremy DAWN Common Stock S - Sale D 17,8753 −70 051 −1 252 651 762
2024-05-03 2024-05-03 4 York Charles N II DAWN Common Stock S - Sale D 17,8527 −8 078 −144 217 293
2024-05-03 2024-05-02 4 York Charles N II DAWN Common Stock S - Sale D 17,8955 −200 −4 225 371
2024-05-03 2024-05-01 4 York Charles N II DAWN Common Stock S - Sale D 17,8870 −52 183 −933 225 571
2024-04-22 2024-04-18 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,0163 −10 000 −160 1 174 662
2024-03-26 2024-03-25 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,0055 −10 000 −160 1 184 662
2024-03-13 2024-03-11 4 Blackman Samuel C. DAWN Common Stock S - Sale D 15,2438 −30 000 −457 1 194 662
2024-02-28 2024-02-27 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,1083 −20 000 −322 1 224 662
2024-02-20 2024-02-16 4 Dubow Adam DAWN Common Stock S - Sale D 15,2481 −3 242 −49 16 585
2024-02-20 2024-02-15 4 Dubow Adam DAWN Common Stock M - Exercise D 3 687 19 827
2024-02-20 2024-02-15 4 Dubow Adam DAWN Common Stock M - Exercise D 1 750 16 140
2024-02-20 2024-02-15 4 Dubow Adam DAWN Common Stock M - Exercise D 2 962 14 390
2024-02-20 2024-02-16 4 York Charles N II DAWN Common Stock S - Sale D 15,2481 −2 666 −41 277 754
2024-02-20 2024-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 6 625 280 420
2024-02-20 2024-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 273 795
2024-02-20 2024-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 271 545
2024-02-20 2024-02-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 15,2481 −2 258 −34 1 244 662
2024-02-20 2024-02-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 6 062 1 246 920
2024-02-20 2024-02-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 437 1 240 858
2024-02-20 2024-02-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 239 421
2024-02-20 2024-02-16 4 Bender Jeremy DAWN Common Stock S - Sale D 15,2481 −7 615 −116 721 813
2024-02-20 2024-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 11 687 729 428
2024-02-20 2024-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 717 741
2024-02-20 2024-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 712 991
2023-11-17 2023-11-16 4 York Charles N II DAWN Common Stock S - Sale D 11,6900 −956 −11 270 170
2023-11-17 2023-11-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 271 126
2023-11-17 2023-11-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 268 876
2023-11-17 2023-11-16 4 Dubow Adam DAWN Common Stock S - Sale D 11,6900 −5 313 −62 11 428
2023-11-17 2023-11-15 4 Dubow Adam DAWN Common Stock M - Exercise D 1 750 16 741
2023-11-17 2023-11-15 4 Dubow Adam DAWN Common Stock M - Exercise D 11 850 14 991
2023-11-17 2023-11-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 11,6900 −709 −8 1 238 234
2023-11-17 2023-11-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 437 1 238 943
2023-11-17 2023-11-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 237 506
2023-11-17 2023-11-16 4 Bender Jeremy DAWN Common Stock S - Sale D 11,6900 −3 107 −36 709 429
2023-11-17 2023-11-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 712 536
2023-11-17 2023-11-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 707 786
2023-11-16 3 Dubow Adam DAWN Common Stock D 3 141
2023-10-20 2023-10-20 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 9,9734 111 387 1 111 12 929 322
2023-10-20 2023-10-19 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 10,0608 384 400 3 867 12 817 935
2023-10-20 2023-10-18 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 10,2076 979 667 10 000 12 433 535
2023-08-17 2023-08-17 4 York Charles N II DAWN Common Stock S - Sale D 13,8600 −922 −13 267 501
2023-08-17 2023-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 268 423
2023-08-17 2023-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 266 173
2023-08-17 2023-08-17 4 Blackman Samuel C. DAWN Common Stock S - Sale D 13,8600 −668 −9 1 236 319
2023-08-17 2023-08-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 437 1 236 987
2023-08-17 2023-08-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 235 550
2023-08-17 2023-08-17 4 Bender Jeremy DAWN Common Stock S - Sale D 13,8600 −2 996 −42 704 224
2023-08-17 2023-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 707 220
2023-08-17 2023-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 702 470
2023-07-05 2023-07-01 4 Bender Jeremy DAWN Common Stock G - Gift I 29 938 270 226
2023-07-05 2023-07-01 4 Bender Jeremy DAWN Common Stock G - Gift I −29 938 251 636
2023-07-05 2023-07-01 4 Bender Jeremy DAWN Common Stock G - Gift I 59 737 300 025
2023-07-05 2023-07-01 4 Bender Jeremy DAWN Common Stock G - Gift I −59 737 221 837
2023-07-05 2023-07-01 4 Bender Jeremy DAWN Common Stock G - Gift I 240 288 240 288
2023-07-05 2023-07-01 4 Bender Jeremy DAWN Common Stock G - Gift I 240 288 240 288
2023-07-05 2023-07-01 4 Bender Jeremy By Melissa Claire Bender DAWN Common Stock G - Gift I −240 288 0
2023-07-05 2023-07-01 4 Bender Jeremy DAWN Common Stock G - Gift D −240 288 0
2023-07-05 2023-07-01 4 Bender Jeremy By Melissa Claire Bender DAWN Common Stock J - Other I 240 288 240 288
2023-07-05 2023-07-01 4 Bender Jeremy DAWN Common Stock J - Other D −240 288 939 196
2023-06-12 2023-06-09 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 13,0000 769 230 10 000 11 453 868
2023-06-07 2023-06-05 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,0000 −1 229 −20 1 234 363
2023-05-17 2023-05-16 4 York Charles N II DAWN Common Stock S - Sale D 13,1223 −955 −13 264 798
2023-05-17 2023-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 265 753
2023-05-17 2023-05-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 263 503
2023-05-17 2023-05-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 13,1223 −692 −9 1 235 592
2023-05-17 2023-05-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 437 1 236 284
2023-05-17 2023-05-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 234 847
2023-05-17 2023-05-16 4 Bender Jeremy DAWN Common Stock S - Sale D 13,1223 −3 104 −41 1 179 484
2023-05-17 2023-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 1 182 588
2023-05-17 2023-05-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 1 177 838
2023-03-14 2023-03-10 4 Blackman Samuel C. DAWN Common Stock S - Sale D 18,0484 −10 000 −180 1 233 660
2023-03-08 2023-03-07 4 Bender Jeremy DAWN Common Stock S - Sale D 20,0091 −12 500 −250 1 174 276
2023-03-03 2023-03-01 4 Papanek Julie DAWN Common Stock S - Sale I 18,6121 −25 000 −465 330 000
2023-02-21 2023-02-17 4 York Charles N II DAWN Common Stock S - Sale D 20,0267 −9 377 −188 262 128
2023-02-17 2023-02-16 4 York Charles N II DAWN Common Stock S - Sale D 19,5730 −930 −18 271 505
2023-02-17 2023-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 2 250 272 435
2023-02-17 2023-02-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 270 185
2023-02-17 2023-02-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 19,5730 −674 −13 1 243 660
2023-02-17 2023-02-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 437 1 244 334
2023-02-17 2023-02-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 242 897
2023-02-17 2023-02-16 4 Bender Jeremy DAWN Common Stock S - Sale D 19,5730 −3 022 −59 1 186 776
2023-02-17 2023-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 4 750 1 189 798
2023-02-17 2023-02-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 1 185 048
2023-02-13 2023-02-10 4 Blackman Samuel C. DAWN Common Stock S - Sale D 20,0659 −10 000 −201 1 241 710
2023-02-13 2022-03-31 5 Bender Jeremy DAWN Common Stock G - Gift I 281 574 281 574
2023-02-13 2022-03-31 5 Bender Jeremy DAWN Common Stock G - Gift I 281 574 281 574
2023-02-13 2022-03-31 5 Bender Jeremy DAWN Common Stock G - Gift D −281 574 1 192 424
2023-02-13 2022-03-31 5 Bender Jeremy DAWN Common Stock G - Gift D −281 574 1 192 424
2023-02-03 2023-02-01 4 Papanek Julie DAWN Common Stock S - Sale I 21,6892 −1 106 −24 355 000
2023-02-03 2023-02-01 4 Papanek Julie DAWN Common Stock S - Sale I 21,2106 −23 894 −507 356 106
2023-01-24 2023-01-23 4 Bender Jeremy DAWN Common Stock S - Sale D 21,9990 −12 500 −275 1 181 486
2023-01-23 2023-01-20 4 York Charles N II DAWN Common Stock S - Sale D 22,7523 −10 000 −228 268 810
2023-01-11 2023-01-10 4 Blackman Samuel C. DAWN Common Stock S - Sale D 23,2045 −2 500 −58 1 250 148
2023-01-11 2023-01-10 4 Blackman Samuel C. DAWN Common Stock S - Sale D 22,7510 −7 500 −171 1 252 648
2023-01-04 2023-01-03 4 Papanek Julie DAWN Common Stock S - Sale I 21,3106 −7 610 −162 380 000
2023-01-04 2023-01-03 4 Papanek Julie DAWN Common Stock S - Sale I 20,3550 −17 390 −354 387 610
2022-12-22 2022-12-21 4 Bender Jeremy DAWN Common Stock S - Sale D 20,3175 −12 500 −254 1 192 424
2022-12-22 2022-12-20 4 York Charles N II DAWN Common Stock S - Sale D 20,0650 −10 000 −201 276 497
2022-12-14 2022-12-12 4 Atlas Venture Fund XI, L.P. DAWN Common Stock J - Other D −600 854 6 008 534
2022-12-12 2022-12-08 4 Papanek Julie DAWN Common Stock S - Sale I 22,0767 −4 358 −96 405 000
2022-12-05 2022-12-02 4 Papanek Julie DAWN Common Stock S - Sale I 21,5452 −5 000 −108 409 358
2022-12-05 2022-12-01 4 Papanek Julie DAWN Common Stock S - Sale I 22,3375 −240 −5 414 358
2022-12-05 2022-12-01 4 Papanek Julie DAWN Common Stock S - Sale I 21,7213 −4 760 −103 414 598
2022-12-05 2022-12-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 22,1556 −900 −20 1 260 148
2022-12-05 2022-12-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 21,3835 −9 100 −195 1 261 048
2022-11-22 2022-11-21 4 York Charles N II DAWN Common Stock S - Sale D 21,3900 −300 −6 286 497
2022-11-22 2022-11-21 4 York Charles N II DAWN Common Stock S - Sale D 20,7374 −9 700 −201 286 797
2022-11-22 2022-11-21 4 Bender Jeremy DAWN Common Stock S - Sale D 21,3800 −400 −9 1 204 924
2022-11-22 2022-11-21 4 Bender Jeremy DAWN Common Stock S - Sale D 20,7378 −12 100 −251 1 205 324
2022-11-17 2022-11-16 4 Bender Jeremy DAWN Common Stock S - Sale D 21,4598 −1 513 −32 1 217 424
2022-11-17 2022-11-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 3 562 1 218 937
2022-11-17 2022-11-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 21,4598 −377 −8 1 270 148
2022-11-17 2022-11-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 1 187 1 270 525
2022-11-17 2022-11-16 4 York Charles N II DAWN Common Stock S - Sale D 21,4598 −430 −9 296 497
2022-11-17 2022-11-15 4 York Charles N II DAWN Common Stock M - Exercise D 1 375 295 776
2022-11-03 2022-11-01 4 York Charles N II DAWN Common Stock S - Sale D 20,0313 −10 000 −200 294 401
2022-11-03 2022-11-02 4 Papanek Julie DAWN Common Stock S - Sale I 20,0138 −5 000 −100 419 358
2022-11-03 2022-11-01 4 Papanek Julie DAWN Common Stock S - Sale I 20,0417 −5 000 −100 424 358
2022-11-03 2022-11-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 20,0050 −10 000 −200 1 269 338
2022-11-03 2022-11-01 4 Bender Jeremy DAWN Common Stock S - Sale D 20,0284 −12 500 −250 1 215 375
2022-10-05 2022-10-03 4 York Charles N II DAWN Common Stock S - Sale D 20,0473 −10 000 −200 304 401
2022-10-05 2022-10-04 4 Papanek Julie DAWN Common Stock S - Sale I 20,0000 −5 000 −100 429 358
2022-10-05 2022-10-03 4 Papanek Julie DAWN Common Stock S - Sale I 20,0630 −5 000 −100 434 358
2022-10-05 2022-10-03 4 Blackman Samuel C. DAWN Common Stock S - Sale D 19,9852 −10 000 −200 1 279 338
2022-10-05 2022-10-03 4 Bender Jeremy DAWN Common Stock S - Sale D 20,0517 −12 500 −251 1 227 875
2022-09-22 2022-09-21 4 Papanek Julie DAWN Common Stock J - Other I −1 500 000 6 964 301
2022-09-22 2022-09-21 4 Papanek Julie DAWN Common Stock S - Sale I 19,2900 −6 106 −118 8 464 301
2022-09-22 2022-09-21 4 Papanek Julie DAWN Common Stock S - Sale I 18,5400 −607 497 −11 263 8 470 407
2022-09-22 2022-09-21 4 Canaan XI L.P. DAWN Common Stock J - Other D −1 500 000 6 964 301
2022-09-22 2022-09-21 4 Canaan XI L.P. DAWN Common Stock S - Sale D 19,2900 −6 106 −118 8 464 301
2022-09-22 2022-09-21 4 Canaan XI L.P. DAWN Common Stock S - Sale D 18,5400 −607 497 −11 263 8 470 407
2022-09-21 2022-09-19 4 Atlas Venture Fund XI, L.P. DAWN Common Stock J - Other D −600 854 6 609 388
2022-09-20 2022-09-20 4 Papanek Julie DAWN Common Stock S - Sale I 20,1000 −2 266 −46 9 077 904
2022-09-20 2022-09-20 4 Papanek Julie DAWN Common Stock S - Sale I 19,5000 −146 404 −2 855 9 080 170
2022-09-20 2022-09-19 4 Papanek Julie DAWN Common Stock S - Sale I 20,5700 −76 725 −1 578 9 226 574
2022-09-20 2022-09-16 4 Papanek Julie DAWN Common Stock S - Sale I 22,0400 −3 722 −82 9 303 299
2022-09-20 2022-09-16 4 Papanek Julie DAWN Common Stock S - Sale I 21,5300 −111 585 −2 402 9 307 021
2022-09-20 2022-09-20 4 Canaan XI L.P. DAWN Common Stock S - Sale D 20,1000 −2 266 −46 9 077 904
2022-09-20 2022-09-20 4 Canaan XI L.P. DAWN Common Stock S - Sale D 19,5000 −146 404 −2 855 9 080 170
2022-09-20 2022-09-19 4 Canaan XI L.P. DAWN Common Stock S - Sale D 20,5700 −76 725 −1 578 9 226 574
2022-09-20 2022-09-16 4 Canaan XI L.P. DAWN Common Stock S - Sale D 22,0400 −3 722 −82 9 303 299
2022-09-20 2022-09-16 4 Canaan XI L.P. DAWN Common Stock S - Sale D 21,5300 −111 585 −2 402 9 307 021
2022-09-15 2022-09-15 4 Papanek Julie DAWN Common Stock S - Sale I 23,7300 −3 314 −79 9 418 606
2022-09-15 2022-09-15 4 Papanek Julie DAWN Common Stock S - Sale I 22,7900 −47 967 −1 093 9 421 920
2022-09-15 2022-09-14 4 Papanek Julie DAWN Common Stock S - Sale I 24,2900 −384 −9 9 469 887
2022-09-15 2022-09-14 4 Papanek Julie DAWN Common Stock S - Sale I 23,6800 −105 727 −2 504 9 470 271
2022-09-15 2022-09-13 4 Papanek Julie DAWN Common Stock S - Sale I 25,0100 −1 003 −25 9 575 998
2022-09-15 2022-09-13 4 Papanek Julie DAWN Common Stock S - Sale I 24,3900 −86 644 −2 113 9 577 001
2022-09-15 2022-09-15 4 Canaan XI L.P. DAWN Common Stock S - Sale D 23,7300 −3 314 −79 9 418 606
2022-09-15 2022-09-15 4 Canaan XI L.P. DAWN Common Stock S - Sale D 22,7900 −47 967 −1 093 9 421 920
2022-09-15 2022-09-14 4 Canaan XI L.P. DAWN Common Stock S - Sale D 24,2900 −384 −9 9 469 887
2022-09-15 2022-09-14 4 Canaan XI L.P. DAWN Common Stock S - Sale D 23,6800 −105 727 −2 504 9 470 271
2022-09-15 2022-09-13 4 Canaan XI L.P. DAWN Common Stock S - Sale D 25,0100 −1 003 −25 9 575 998
2022-09-15 2022-09-13 4 Canaan XI L.P. DAWN Common Stock S - Sale D 24,3900 −86 644 −2 113 9 577 001
2022-09-15 2022-09-02 4 Papanek Julie DAWN Common Stock S - Sale I 23,8215 −5 000 −119 439 358
2022-09-14 3 Nicholson Garry A DAWN No securities beneficially owned. D 0
2022-09-06 2022-09-01 4 York Charles N II DAWN Common Stock S - Sale D 23,7987 −1 394 −33 314 401
2022-09-06 2022-09-01 4 York Charles N II DAWN Common Stock S - Sale D 23,1593 −8 606 −199 315 795
2022-09-06 2022-09-01 4 Papanek Julie DAWN Common Stock S - Sale I 23,7958 −531 −13 444 358
2022-09-06 2022-09-01 4 Papanek Julie DAWN Common Stock S - Sale I 23,2094 −4 469 −104 444 889
2022-09-06 2022-09-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 23,7938 −1 589 −38 1 289 338
2022-09-06 2022-09-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 23,1415 −8 411 −195 1 290 927
2022-09-06 2022-09-01 4 Bender Jeremy DAWN Common Stock S - Sale D 23,7905 −1 859 −44 1 240 375
2022-09-06 2022-09-01 4 Bender Jeremy DAWN Common Stock S - Sale D 23,1514 −10 641 −246 1 242 234
2022-09-06 2022-09-01 4 Bender Jeremy DAWN Common Stock S - Sale D 23,7905 −1 859 −44 1 240 375
2022-09-06 2022-09-01 4 Bender Jeremy DAWN Common Stock S - Sale D 23,1514 −10 641 −246 1 242 234
2022-08-17 2022-08-16 4 Blackman Samuel C. DAWN Common Stock S - Sale D 24,3100 −941 −23 1 299 338
2022-08-17 2022-08-15 4 Blackman Samuel C. DAWN Common Stock M - Exercise D 3 561 1 300 279
2022-08-17 2022-08-16 4 Bender Jeremy DAWN Common Stock S - Sale D 24,3100 −4 003 −97 1 252 875
2022-08-17 2022-08-15 4 Bender Jeremy DAWN Common Stock M - Exercise D 10 686 1 256 878
2022-08-17 2022-08-16 4 York Charles N II DAWN Common Stock S - Sale D 24,3100 −1 089 −26 324 401
2022-08-17 2022-08-15 4 York Charles N II DAWN Common Stock M - Exercise D 4 125 325 490
2022-08-08 2022-08-05 4 Papanek Julie DAWN Common Stock S - Sale I 20,0000 −5 000 −100 449 358
2022-08-08 2022-08-04 4 Papanek Julie DAWN Common Stock S - Sale I 20,0008 −5 000 −100 454 358
2022-08-05 2022-08-04 4 Bender Jeremy DAWN Common Stock S - Sale D 20,0017 −12 500 −250 1 246 192
2022-08-05 2022-08-04 4 York Charles N II DAWN Common Stock S - Sale D 20,0541 −10 000 −201 321 365
2022-08-03 2022-08-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,8810 −10 000 −169 1 296 718
2022-07-20 2022-07-18 4 Papanek Julie DAWN Common Stock S - Sale I 20,0004 −2 600 −52 459 358
2022-07-20 2022-07-18 4 York Charles N II DAWN Common Stock S - Sale D 20,0000 −2 500 −50 331 365
2022-07-20 2022-07-18 4 Bender Jeremy DAWN Common Stock S - Sale D 20,0012 −2 600 −52 1 258 692
2022-07-12 2022-07-05 4/A Papanek Julie DAWN Common Stock S - Sale I 20,0000 −800 −16 463 200
2022-07-12 2022-07-01 4/A Papanek Julie DAWN Common Stock S - Sale I 20,0000 −1 000 −20 464 000
2022-07-12 2021-11-03 5 Papanek Julie DAWN Common Stock G - Gift I 465 000 465 000
2022-07-12 2021-11-03 5 Papanek Julie DAWN Common Stock G - Gift D −465 000 0
2022-07-12 2022-07-08 4 Papanek Julie DAWN Common Stock S - Sale I 20,0000 −1 242 −25 461 958
2022-07-12 2022-07-08 4 York Charles N II DAWN Common Stock S - Sale D 20,0000 −1 416 −28 333 865
2022-07-12 2022-07-08 4 Bender Jeremy DAWN Common Stock S - Sale D 20,0000 −1 795 −36 1 261 292
2022-07-06 2022-07-05 4 York Charles N II DAWN Common Stock S - Sale D 20,0000 −800 −16 335 281
2022-07-06 2022-07-01 4 York Charles N II DAWN Common Stock S - Sale D 20,0000 −1 479 −30 336 081
2022-07-06 2022-07-05 4 Papanek Julie The Grant Family Delaware Trust DAWN Common Stock S - Sale I 20,0000 −800 −16 463 200
2022-07-06 2022-07-01 4 Papanek Julie The Grant Family Delaware Trust DAWN Common Stock S - Sale I 20,0000 −1 000 −20 464 000
2022-07-06 2022-07-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 19,9495 −867 −17 1 306 718
2022-07-06 2022-07-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 19,2279 −3 309 −64 1 307 585
2022-07-06 2022-07-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 18,2412 −5 824 −106 1 310 894
2022-07-06 2022-07-05 4 Bender Jeremy DAWN Common Stock S - Sale D 20,0000 −857 −17 1 263 087
2022-07-06 2022-07-01 4 Bender Jeremy DAWN Common Stock S - Sale D 20,0000 −1 746 −35 1 263 944
2022-07-06 2022-07-01 4 Atlas Venture Opportunity Fund I, L.P. DAWN Common Stock J - Other D −198 280 793 116
2022-06-22 2022-06-17 4 Atlas Venture Opportunity Fund II, L.P. DAWN Common Stock P - Purchase D 15,0000 766 667 11 500 766 667
2022-06-22 2022-06-17 4 Gladstone Michael DAWN Common Stock P - Purchase I 15,0000 766 667 11 500 766 667
2022-06-21 2022-06-17 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 15,0000 1 200 000 18 000 10 684 638
2022-06-17 2022-06-15 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,2631 −50 000 −813 1 316 718
2022-01-20 2022-01-18 4 York Charles N II DAWN Restricted Stock Units A - Award D 22 000 22 000
2022-01-20 2022-01-18 4 York Charles N II DAWN Stock Option (right to buy Common Stock) A - Award D 14,26 151 000 151 000
2022-01-20 2022-01-18 4 Blackman Samuel C. DAWN Restricted Stock Units A - Award D 19 000 19 000
2022-01-20 2022-01-18 4 Blackman Samuel C. DAWN Stock Option (right to buy Common Stock) A - Award D 14,26 135 000 135 000
2022-01-20 2022-01-18 4 Bender Jeremy DAWN Restricted Stock Units A - Award D 57 000 57 000
2022-01-20 2022-01-18 4 Bender Jeremy DAWN Stock Option (right to buy Common Stock) A - Award D 14,26 397 000 397 000
2022-01-20 2022-01-20 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 14,7293 4 615 68 9 484 638
2022-01-20 2022-01-19 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 14,6990 58 818 865 9 480 023
2022-01-20 2022-01-18 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 14,2616 43 429 619 9 421 205
2022-01-05 2022-01-03 4 Blackman Samuel C. DAWN Common Stock S - Sale D 17,4111 −3 328 −58 1 366 718
2022-01-05 2022-01-03 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,9475 −6 672 −113 1 370 046
2021-12-22 2021-12-21 4 Canaan XI L.P. DAWN Common Stock J - Other D −536 000 9 663 645
2021-12-09 2021-12-08 4 Canaan XI L.P. DAWN Common Stock J - Other D −536 000 10 199 645
2021-12-09 2021-12-08 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses DAWN Common Stock S - Sale I 18,0300 −110 338 −1 989 6 120 124
2021-12-09 2021-12-07 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses DAWN Common Stock S - Sale I 19,5000 −58 190 −1 135 6 230 462
2021-12-09 2021-12-07 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses DAWN Common Stock S - Sale I 18,4300 −128 745 −2 373 6 288 652
2021-12-07 2021-12-06 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses DAWN Common Stock S - Sale I 18,0500 −97 692 −1 763 6 417 397
2021-12-07 2021-12-03 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses DAWN Common Stock S - Sale I 18,4700 −12 517 −231 6 515 089
2021-12-03 2021-12-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 18,2435 −409 −7 1 376 718
2021-12-03 2021-12-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 17,8119 −4 502 −80 1 377 127
2021-12-03 2021-12-01 4 Blackman Samuel C. DAWN Common Stock S - Sale D 16,6224 −5 089 −85 1 381 629
2021-12-03 2021-10-22 4 Blackman Samuel C. By the 2021 Blackman Family LLC DAWN Common Stock G - Gift I 1 000 000 1 000 000
2021-12-03 2021-10-22 4 Blackman Samuel C. DAWN Common Stock G - Gift D −1 000 000 1 386 718
2021-11-29 2021-11-24 4 Atlas Venture Fund XI, L.P. DAWN Common Stock J - Other D −801 138 7 210 242
2021-11-29 2021-11-24 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses DAWN Common Stock J - Other I 57 224 6 527 606
2021-08-18 2021-08-16 4 Garland J. Scott DAWN Stock Option (Right to buy Common Stock) A - Award D 24,65 48 072 48 072
2021-08-18 3 Garland J. Scott DAWN No securities beneficially owned. D 0
2021-06-03 2021-06-01 4 AI Day 1 LLC DAWN Series B Redeemable Convertible Preferred Stock C - Conversion D −741 396 0
2021-06-03 2021-06-01 4 AI Day 1 LLC DAWN Series A Redeemable Convertible Preferred Stock C - Conversion D −7 761 380 0
2021-06-03 2021-06-01 4 AI Day 1 LLC DAWN Common Stock P - Purchase D 16,0000 875 000 14 000 9 377 776
2021-06-03 2021-06-01 4 AI Day 1 LLC DAWN Common Stock C - Conversion D 8 502 776 8 502 776
2021-06-02 2021-06-01 4 Papanek Julie By Canaan XI, L.P. DAWN Series B Preferred Stock C - Conversion I −148 279 0
2021-06-02 2021-06-01 4 Papanek Julie By Canaan XI, L.P. DAWN Series A Preferred Stock C - Conversion I −7 328 497 0
2021-06-02 2021-06-01 4 Papanek Julie By Canaan XI, L.P. DAWN Common Stock P - Purchase I 16,0000 13 000 208 10 735 645
2021-06-02 2021-06-01 4 Papanek Julie By Canaan XI, L.P. DAWN Common Stock C - Conversion I 148 279 10 722 645
2021-06-02 2021-06-01 4 Papanek Julie By Canaan XI, L.P. DAWN Common Stock C - Conversion I 7 328 497 10 574 366
2021-06-02 2021-05-26 4 Papanek Julie DAWN Stock Option (right to buy Common Stock) A - Award D 16,00 63 000 63 000
2021-06-02 2021-02-01 4 Papanek Julie By Canaan XI, L.P. DAWN Series B Preferred Stock A - Award I 148 279 148 279
2021-06-02 2021-06-01 4 Atlas Venture Fund XI, L.P. DAWN Series B Preferred Stock C - Conversion I −741 396 0
2021-06-02 2021-06-01 4 Atlas Venture Fund XI, L.P. DAWN Series A Preferred Stock C - Conversion I −7 761 380 0
2021-06-02 2021-06-01 4 Atlas Venture Fund XI, L.P. DAWN Common Stock P - Purchase I 16,0000 250 000 4 000 250 000
2021-06-02 2021-06-01 4 Atlas Venture Fund XI, L.P. DAWN Common Stock P - Purchase I 16,0000 250 000 4 000 250 000
2021-06-02 2021-06-01 4 Atlas Venture Fund XI, L.P. DAWN Common Stock C - Conversion I 741 396 741 396
2021-06-02 2021-06-01 4 Atlas Venture Fund XI, L.P. DAWN Common Stock C - Conversion I 7 761 380 7 761 380
2021-06-02 2021-02-01 4 Atlas Venture Fund XI, L.P. DAWN Series B Preferred Stock P - Purchase I 741 396 741 396
2021-06-02 2021-06-01 4 Canaan XI L.P. DAWN Series B Preferred Stock C - Conversion D −148 279 0
2021-06-02 2021-06-01 4 Canaan XI L.P. DAWN Series A Preferred Stock C - Conversion D −7 328 497 0
2021-06-02 2021-06-01 4 Canaan XI L.P. DAWN Common Stock P - Purchase D 16,0000 13 000 208 10 735 645
2021-06-02 2021-06-01 4 Canaan XI L.P. DAWN Common Stock C - Conversion D 148 279 10 722 645
2021-06-02 2021-06-01 4 Canaan XI L.P. DAWN Common Stock C - Conversion D 7 328 497 10 574 366
2021-06-01 2021-06-01 4 Josey John A. DAWN Common Stock P - Purchase D 16,0000 7 000 112 72 292
2021-06-01 2021-05-26 4 Josey John A. DAWN Stock Option (right to buy Common Stock) A - Award D 16,00 1 181 1 181
2021-06-01 2021-05-26 4 Josey John A. DAWN Stock Option (right to buy Common Stock) A - Award D 16,00 63 000 63 000
2021-06-01 2021-06-01 4 Becker Daniel J. DAWN Common Stock P - Purchase D 16,0000 5 000 80 5 000
2021-06-01 2021-05-26 4 Becker Daniel J. DAWN Stock Option (right to buy Common Stock) A - Award D 16,00 63 000 63 000
2021-05-26 3 Papanek Julie By Canaan XI, L.P. DAWN Common Stock I 3 245 869
2021-05-26 3 Papanek Julie DAWN Common Stock D 465 000
2021-05-26 3 Ramasastry Saira DAWN Common Stock D 50 485
2021-05-26 3 Josey John A. DAWN Common Stock D 65 292
2021-05-26 3 Holles Natalie C. DAWN Common Stock D 57 310
2021-05-26 3 Blackman Samuel C. DAWN Common Stock D 2 386 718
2021-05-26 3 York Charles N II DAWN Common Stock D 337 560
2021-05-26 3 Bender Jeremy DAWN Common Stock D 1 828 838
2021-05-26 3 MILLENNIUM PHARMACEUTICALS INC See Explanation of Responses DAWN Common Stock I 6 470 382
2021-05-26 3 Canaan Partners XI LLC DAWN Common Stock D 3 245 869
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista